ASTRAZEN.NS

AstraZeneca Pharma India Limited [ASTRAZEN.NS] Stock Forecast

Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000

ASTRAZEN.NS Stock Summary

Top 10 Correlated ETFs

ASTRAZEN.NS

Top 10 Correlated Stocks

ASTRAZEN.NS

In the News

ASTRAZEN.NS Financial details

Company Rating
-
Market Cap
132.69B
Income
1.39B
Revenue
11.97B
Book val./share
-
Cash/share
-
Dividend
16
Dividend %
0.24%
Employees
947
Optionable
No
Shortable
Yes
Earnings
28 May 2024
P/E
110.59
Forward P/E
-
PEG
8.77
P/S
14.81
P/B
25.8
P/C
-
P/FCF
7130.8
Quick Ratio
1.52
Current Ratio
2.19
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
55.72
EPS next Y
-
EPS next Q
-
EPS this Y
61.2%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
12.77%
Revenue last 5Y
6.61%
Revenue Q/Q
-1.7%
EPS Q/Q
-69.83%
-
-
-
-
SMA20
5.87%
SMA50
17.61%
SMA100
35.32%
Inst Own
-
Inst Trans
-
ROA
14%
ROE
49%
ROC
0.29%
Gross Margin
54%
Oper. Margin
17%
Profit Margin
13%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
3098.0-7220.95
52W High
+20.24%
52W Low
+180.21%
RSI
56.29
Rel Volume
0.58
Avg Volume
20.6K
Volume
11.92K
Perf Week
-0.53%
Perf Month
12.64%
Perf Quarter
14.97%
Perf Half Y
22.95%
-
-
-
-
Beta
0.38
-
-
Volatility
126.53%, 392.23%
Prev Close
-1.29%
Price
8681
Change
-1.69%

ASTRAZEN.NS Financial Performance

ASTRAZEN.NS Dividend History

ASTRAZEN.NS Frequently Asked Questions

What is AstraZeneca Pharma India Limited stock symbol ?

AstraZeneca Pharma India Limited is a IN stock and trading under the symbol ASTRAZEN.NS

What is AstraZeneca Pharma India Limited stock quote today ?

AstraZeneca Pharma India Limited stock price is $8681 today.

Is AstraZeneca Pharma India Limited stock public?

Yes, AstraZeneca Pharma India Limited is a publicly traded company.

Something similar

Top by Market Cap
BRK-A
LLY.DE
0YXG.L
BRYN.DE
M&M.NS
Top Correlated ETFs
ABSLNN50ET.NS
MOM100.NS
MOM50.NS
ICICIB22.NS
Top Correlated Stocks
KIMS.NS
BAJFINANCE.NS
GRAVITA.NS
GUJGASLTD.NS
SBICARD.NS
Similar Market Cap
AXAHY
044450.KS
BEIJ-B.ST
600760.SS
NATCOPHARM.NS

Company Profile

Healthcare Drug Manufacturers - Specialty & Generic
  • Volume Average 20.6K
  • Market Capitalization 132.69B
  • Employee 947
  • CEO Dr. Sanjeev Kumar Panchal
  • Headquarters Bengaluru,IN
  • IPO Date 2002-07-01
  • Website https://www.astrazeneca.in

AstraZeneca Pharma India Limited, a biopharmaceutical company, manufactures, distributes, and markets pharmaceutical products in India and internationally. It manufactures and sells cardiovascular disease and diabetes medicines under the Brilinta, Betaloc, Crestor, Forxiga, Imdur, Kombiglyze XR, Onglyza, Seloken XL, Xigduo XR, and QTERN brands; Respiratory medicines under the Symbicort and FASENRA brand names; and oncology medicines under the LYNPARZA, Tagrisso, Iressa, Calquence, Casodex, Faslodex, Zoladex, and Arimidex brands. The company also offers products in the areas of renal, metabolic, and immunology diseases. It also provides clinical trial services. The company was incorporated in 1979 and is based in Bengaluru, India. AstraZeneca Pharma India Limited is a subsidiary of AstraZeneca Pharmaceuticals AB.